Skip to content

Effect of PP in Patients With Ultra-low VT

Physiological Effect of Prone Position in Patients With Ultra-low Tidal Volume Ventilation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06215209
Enrollment
45
Registered
2024-01-22
Start date
2024-02-20
Completion date
2025-04-01
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome, Prone Position, Tidal Volume

Brief summary

Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome with similar clinicopathological feathers caused by different etiologies. Respiratory supportive strategies is the main ARDS management, and the guidelines recommend low tidal volume to improve clinical outcomes. To be note, overdistension can still occur even if using a tidal volume as low as 6 ml/kg, given the heterogeneous nature of the syndrome. Therefore, adjusting tidal volume level to less than 6ml/kg may reduce ventilator-induced lung injury (VILI) and thus improve outcomes, especially in patients with severe lung injury. Prone position is also an important management in severe ARDS. Prone position can improve ventilation-perfusion (V/Q) matching and reduce the risk of VILI by recruiting dorsal collapsed alveoli. Meanwhile, prone position has also been shown to improve hemodynamics. Recent studies have showed that prone position did not reduce duration of venovenous extracorporeal membrane oxygenation (VV-ECMO) and 90-day mortality in patients with ARDS who receive VV-ECMO with ultra-low tidal volume ventilation. Therefore, the effect of PP on ventilation and lung blood flow in ARDS patients treated with VV-ECMO wiht ultra-low tidal volume ventilation remains unclear.

Interventions

OTHERposition

patients will be in supine position and prone position

Sponsors

Southeast University, China
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients were enrolled if they were undergoing invasive mechanical ventilation and were supported by VV-ECMO for less than 48 hours

Exclusion criteria

* younger than 18 years old * contraindications for prone position ventilation * past chronic respiratory diseases (long-term family oxygen therapy for chronic * respiratory diseases such as pulmonary fibrosis or COPD) * New York Heart Association class above II * contraindications to the use of EIT (e.g., presence of pacemaker or chest surgical wounds dressing) or prone position (as decided by the attending physician) * severe hemodynamic instability * gave written or witnessed verbal informed consent

Design outcomes

Primary

MeasureTime frameDescription
ventilation-perfusion mathchingup to 24 hoursventilation-perfusion matching will be monitored using an EIT monitor (PulmoVista® 500, Dräger, Lübeck, Germany) in supine position and prone position

Secondary

MeasureTime frameDescription
The percentage of dead spaceup to 24 hoursThe percentage of shunt will be monitored using an EIT monitor (PulmoVista® 500, Dräger, Lübeck, Germany) in supine position and prone position
The percentage of dorsal ventilationup to 24 hoursThe percentage of dorsal ventilation will be monitored using an EIT monitor (PulmoVista® 500, Dräger, Lübeck, Germany) in supine position and prone position
The percentage of dorsal perfusionup to 24 hoursThe percentage of dorsal ventilation will be monitored using an EIT monitor (PulmoVista® 500, Dräger, Lübeck, Germany) in supine position and prone position
The percentage of shuntup to 24 hoursThe percentage of shunt will be monitored using an EIT monitor (PulmoVista® 500, Dräger, Lübeck, Germany) in supine position and prone position
Regional ventilation delay (RVD)up to 24 hoursRegional ventilation delay will be monitored using an EIT monitor (PulmoVista® 500, Dräger, Lübeck, Germany) in supine position and prone position
Arterial blood gas analysisup to 24 hoursArterial blood gas analysis included pH, PaO2, PaCO2 and PaO2/FiO2 in supine position and prone position
Respiratory system complianceup to 24 hoursRespiratory system compliance will be monitored in supine position and prone position.
Center of ventilation (CoV)up to 24 hoursCenter of ventilation will be monitored using an EIT monitor (PulmoVista® 500, Dräger, Lübeck, Germany) in supine position and prone position

Countries

China

Contacts

Primary Contactliu ling, phD
liulingdoctor@126.com025-83262550

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026